We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+11.06%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.66B
AUM Growth
+$16.3M
Cap. Flow
-$44.8M
Cap. Flow %
-2.69%
Top 10 Hldgs %
48.94%
Holding
82
New
33
Increased
12
Reduced
12
Closed
25

Top Buys

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$73.8M
2
VTRS icon
Viatris
VTRS
+$64.3M
3
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$63M
4
MRK icon
Merck
MRK
+$56.2M
5
ENDP
Endo International plc
ENDP
+$53.9M

Top Sells

Rank Stock Value
1
ARTC
ARTHROCARE CORP
ARTC
+$95.6M
2
AGN
Allergan Inc
AGN
+$94.5M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$68.8M
4
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$50.3M
5
MJN
Mead Johnson Nutrition Company
MJN
+$50.3M

Sector Composition

Rank Sector Weight
1 Healthcare 65.49%
2 Financials 4.97%
3 Technology 1.5%
4 Consumer Staples 0%
5 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DSCI
51
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$3.8M 0.23%
+300,000
New +$3.88M
CSII
52
DELISTED
Cardiovascular Systems, Inc.
CSII
$2.64M 0.16%
83,000
+33,000
+66% +$1.09M
ALXN
53
DELISTED
Alexion Pharmaceuticals
ALXN
$2.63M 0.16%
17,300
-432,700
-96% -$68.8M
ELOS
54
DELISTED
Syneron Medical Ltd
ELOS
$1.51M 0.09%
+121,500
New +$1.44M
RMTI icon
55
Rockwell Medical
RMTI
$28.5M
$1.4M 0.08%
+1,003
New +$1.3M
AEGR
56
DELISTED
Aegerion Pharmaceuticals
AEGR
$1.15M 0.07%
24,800
-825,200
-97% -$48.4M
GLMD icon
57
Galmed Pharmaceuticals
GLMD
$4.83M
$814K 0.05%
+394
New +$923K
ABT icon
58
CALL
Abbott
ABT
$185B
– –
-1,000,000
Closed -$38.3M
BIIB icon
59
Biogen
BIIB
$29.8B
– –
-27,800
Closed -$7.77M
EL icon
60
Estee Lauder
EL
$30.6B
– –
-350,000
Closed -$26.4M
EXEL icon
61
Exelixis
EXEL
$13.8B
– –
-3,100,000
Closed -$21.1M
HCA icon
62
HCA Healthcare
HCA
$88B
– –
-107,000
Closed -$5.11M
INVA icon
63
Innoviva
INVA
$1.53B
– –
-899,725
Closed -$25.8M
ISRG icon
64
Intuitive Surgical
ISRG
$135B
– –
-454,086
Closed -$21.4M
MOH icon
65
Molina Healthcare
MOH
$10.2B
– –
-1,275,000
Closed -$44.3M
TEVA icon
66
CALL
Teva Pharmaceuticals
TEVA
$40.2B
– –
-1,000,000
Closed -$40.1M
TEVA icon
67
Teva Pharmaceuticals
TEVA
$40.2B
– –
-165,200
Closed -$6.62M
THC icon
68
Tenet Healthcare
THC
$20.1B
– –
-600,000
Closed -$25.3M
TMO icon
69
Thermo Fisher Scientific
TMO
$213B
– –
-26,500
Closed -$2.95M
VTRS icon
70
CALL
Viatris
VTRS
$20.5B
– –
-300,000
Closed -$13M
ZBH icon
71
Zimmer Biomet
ZBH
$18.8B
– –
-52,221
Closed -$4.72M
ACGN
72
DELISTED
Aceragen Inc
ACGN
– –
-24,657
Closed -$15.5M
ACOR
73
DELISTED
Acorda Therapeutics
ACOR
– –
-3,333
Closed -$11.7M
MON
74
DELISTED
Monsanto Co
MON
– –
-63,100
Closed -$7.35M
MJN
75
DELISTED
Mead Johnson Nutrition Company
MJN
– –
-600,000
Closed -$50.3M
1 2
3
4

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q1 2014 Portfolio in Review

As of Q1 2014, HealthCor Management held 82 positions worth $1.66B, up 0.99% from $1.65B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

HealthCor Management's Q1 2014 filing shows 33 new, 12 increased, 12 reduced and 25 closed positions. Its largest new stake was MEDIVATION, INC.: 2,000,000 shares worth $64.4M. The largest sale was ARTHROCARE CORP, an estimated $95.6M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 60% a quarter earlier, followed by Financials and Technology.

  • HealthCor Management's largest Q1 2014 buy was MEDIVATION, INC.: 2,000,000 shares worth $64.4M.
  • HealthCor Management added most to Viatris in Q1 2014, an estimated $64.3M increase.
  • HealthCor Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $94.5M.
  • HealthCor Management fully exited ARTHROCARE CORP in Q1 2014, selling an estimated $95.6M.
  • HealthCor Management's ten largest holdings make up 49% of its $1.66B portfolio in Q1 2014.
  • HealthCor Management opened 33 new positions and closed 25 in Q1 2014.
  • HealthCor Management's portfolio value rose 0.99% quarter-over-quarter to $1.66B.

Based on HealthCor Management's 13F filing for Q1 2014, filed 15 May 2014.